All papers - OPEN Foundation

Ketamine and rapid-acting antidepressants: a new era in the battle against depression and suicide

Duman, R. S. | F1000Research | 24 May 2018

Classics in Neuroimaging: The Serotonergic 2A Receptor System-from Discovery to Modern Molecular Imaging

T. L’Estrade, E., Hansen, H. D., Erlandsson, M., Ohlsson, T. G., Knudsen, G. M., & Herth, M. M. | ACS Chemical Neuroscience | 15 May 2018

Relief from intractable phantom pain by combining psilocybin and mirror visual-feedback (MVF)

Ramachandran, V., Chunharas, C., Marcus, Z., Furnish, T., & Lin, A. | Neurocase | 15 May 2018

Are Ecstasy Induced Serotonergic Alterations Overestimated For The Majority Of Users?

Szigeti, B., Winstock, A. R., Erritzoe, D., & Maier, L. J. | Journal of Psychopharmacology | 7 May 2018

Lysergic acid diethylamide and psilocybin for the management of patients with persistent pain: a potential role?

Whelan, A., & Johnson, M. I. | Pain management | 3 May 2018

3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in service personnel

Cipriani, A., & Cowen, P. J. | Lancet Psychiatry | 1 May 2018

The epidemiology of 5-methoxy- N,N-dimethyltryptamine (5-MeO-DMT) use: Benefits, consequences, patterns of use, subjective effects, and reasons for consumption

Davis, A. K., Barsuglia, J. P., Lancelotta, R., Grant, R. M., & Renn, E. | Journal of Psychopharmacology | 30 April 2018

The epidemiology of 5-methoxy-N, N-dimethyltryptamine (5-MeO-DMT) use: Benefits, consequences, patterns of use, subjective effects, and reasons for consumption

Davis, A. K., Barsuglia, J. P., Lancelotta, R., Grant, R. M., & Renn, E. | Journal of Psychopharmacology | 30 April 2018

Gnosis Potency: DMT Breakthroughs and Paragnosis

St John, G. | Plant Medicines, Healing and Psychedelic Science: Cultural Perspectives | 29 April 2018

Integrating Psychedelic Medicines and Psychiatry: Theory and Methods of a Model Clinic

Sloshower, J. | Plant Medicines, Healing and Psychedelic Science: Cultural Perspectives | 29 April 2018

Psychedelic Naturalism and Interspecies Alliance: Views from the Emerging Do-It-Yourself Mycology Movement

Steinhardt, J. | Plant Medicines, Healing and Psychedelic Science: Cultural Perspectives | 29 April 2018

Plant Knowledges: Indigenous Approaches and Interspecies Listening Toward Decolonizing Ayahuasca Research

Dev, L. | Plant Medicines, Healing and Psychedelic Science: Cultural Perspectives | 29 April 2018

Placebo Problems: Boundary Work in the Psychedelic Science Renaissance

Hendy, K. | Plant Medicines, Healing and Psychedelic Science: Cultural Perspectives | 29 April 2018

Bubbling with Controversy: Legal Challenges for Ceremonial Ayahuasca Circles in the United States

Feeney, K., Labate, B. C., & Hudson, J. H. | Plant Medicines, Healing and Psychedelic Science: Cultural Perspectives | 29 April 2018

Undiscovering the Pueblo Mágico: Lessons from Huautla for the Psychedelic Renaissance

Feinberg, B. | Plant Medicines, Healing and Psychedelic Science: Cultural Perspectives | 29 April 2019

Who Is Keeping Tabs? LSD Lessons from the Past for the Future

Dyck, E. | Plant Medicines, Healing and Psychedelic Science: Cultural Perspectives | 29 April 2018

Peyote’s Race Problem

Dawson, A. | Plant Medicines, Healing and Psychedelic Science: Cultural Perspectives | 29 April 2018

The Use of Salvia divinorum from a Mazatec Perspective

Maqueda, A. E. | Plant Medicines, Healing and Psychedelic Science: Cultural Perspectives | 29 April 2018

Whole Organisms or Pure Compounds? Entourage Effect Versus Drug Specificity

Ribeiro, S. | Plant Medicines, Healing and Psychedelic Science: Cultural Perspectives | 29 April 2019

Ibogaine Acute Administration in Rats Promotes Wakefulness, Long-Lasting REM Sleep Suppression, and a Distinctive Motor Profile

González, J., Prieto, J. P., Rodríguez, P., Cavelli, M., Benedetto, L., Mondino, A., ... & Torterolo, P. | Frontiers in pharmacology | 27 April 2018